MOVING LIFE SCIENCE INNOVATIONS

FROM DISCOVERY TO DEVELOPMENT TO DELIVERY

OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.

OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.

OUR MEMBERS: AZBio Members make an impact. They discover, develop and deliver health innovations including medicines, medical devices, diagnostics, and a wide range of health technologies. Our members also include economic development partners, educators, investors, leading business and philanthropic organizations, and patient advocacy organizations. AZBio Members employ over 365,000 Arizonans who are working together to make life better for people in Arizona and around the world.

Our industry sector generated over $43.64 billion in Economic Impact in 2023.

That's up over 88% from 2016 and growing at a Compound Annual Growth Rate of 9.5%.

Arizona’s bioscience industry (not including our hospitals) employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. View More of Arizona's Bioscience Industry Data

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.

AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.

AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.

Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.

2011 AZBio Awards Honorees Announced

The Arizona BioIndustry is Moving Forward Faster in 2011 The Arizona BioIndustry Association has selected finalists and honorees for its annual awards gala to be held at the Sheraton Wild Horse Pass on Oct. 13. Awards to be presented include: 2011 Michael A. Cusanovich Educator of the Year, Fast Lane Company Awards, the Arizona Bioscience Company of the Year, […]

Join AZBio at the Personalized Medicine World Conference

PMWC 2012′s “Into The Clinic” session delves into both companies’ and clinicians’ perspectives with a particular focus on the benefits that patients presently gain from Personalized Medicine, as well as on approaches arriving in the near future. This is one of six sessions showcased in the PMWC 2012 program. Join AZBio and come build your […]

National LambdaRail appoints Crow as head of Chairman’s Advisory Council

September 14, 2011 Patrick Soon-Shiong, chairman and CEO of National LambdaRail, announced the appointment of ASU President Michael M. Crow as head of a new Chairman’s Advisory Council.Aided by a $100 million guarantee from the Chan Soon-Shiong Institute for Advanced Health to upgrade and extend its network to support big science projects, the council will […]

Regenesis Biomedical takes to the stage at the AdvaMed 2011 MedTech

Regenesis Biomedical to Participate in the AdvaMed 2011 MedTech Conference: Selected to present in the Wound Management category and serve as a panelist on Emerging Growth Companies. Scottsdale, Arizona, September 5, 2011 — Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announced today that it was selected to present at the AdvaMed 2011 MedTech conference. Regenesis presents in the […]